CD274 and head and neck squamous cell carcinoma: This is because approximately 80% of patients with HNSCCs are classified as ineligible due to low PD-L1 expression [5–10], and approximately 24% of HNSCC cases may include “immune-cold” tumors exhibiting low immune cell infiltration and immune activity [11].